The company expired its plan on October 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.52 USD | +2.70% | +3.40% | -5.00% |
07-01 | Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) dropped from Russell 3000E Value Index | CI |
07-01 | Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) dropped from Russell 2000 Value Index | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
23.75 USD | +5.51% | +31.22% | 57.78M | ||
1.52 USD | +2.70% | +3.40% | 50.8M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.00% | 50.8M | |
+22.15% | 46.56B | |
+45.26% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Reneo Pharmaceuticals, Inc.'s Equity Buyback announced on October 30, 2023 has expired with 576,443 shares, for $4.4 million.